#MedRxiv

Michael Mina

michaelmina_lab

Moving in right direction to reverse outbreaksHere's how:At-home frequent rapid tests10M/day ->pool 2 ppl/test ->20M ppl tested/day ->Ea house tests 1x/wk ->140M ppl tested/wk!! ->Herd effects: R RAPIDLY

Andrew Steele

statto

These BBC covid explainers have largely been very good, interpreting complex guidance in simple language.But this one uses a travel PR exec who knows no more than anyone else and

J.J. Sylvia IV, Ph.D

BigDataJJ

1/ I've been seeing a lot of discussion about studies that show transmission of COVID-19 does not occur as often from children to adults. This is being used to support

Kaitlyn Sadtler, PhD

KSadtler

By July of 2020, 16.8 million people in the US had #COVID19 -- and didn’t know it. Read our pre-print @medrxivpreprint (1/13)https://www.medrxiv.org/content/10.1101/2021.01.27.21250570v1 We called out for volunteers that never

Emilia C Skirmuntt 🦇🧬🦠

ESkirmuntt

AstraZeneca and South African variant (B1.351 or 501Y.V2) vaccine study (it took me a couple of days but here it is… We will probably have another COVID drama in a

Fionna O'Leary, 🕯🇪🇺

fascinatorfun

Thanks for this incredibly helpful analysis @dgurdasani1 Two questions. 1/ Does this summarise the AZ published data :The plan is to extend the time interval for all age groups despite

Eric Feigl-Ding

DrEricDing

COVID REPLAPSE—New study finds the #SARSCoV2 may remain in people’s brains after infection and trigger relapses in patients who thought they had recovered. This could explain why patients who appear

Prof. Akiko Iwasaki

VirusesImmunity

What aspects of antibody responses determine the outcome of #COVID19? In this new preprint by @carolilucas @sneakyvirus1 et al., we found that the early timing of antibody response (before 14

Leila Mechoui ☃️

leilamechoui

Ok so guess what everyone, I did read that excess death paper from the CDC and it's not some extraordinary dismissal of Briand's article, which was posted and then retracted

Alexandre Bolze

alexbolze

Thread about our preprint on the study of emergence and increased prevalence of SARS-CoV-2 B.1.1.7 variant in the US.https://www.medrxiv.org/content/10.1101/2021.02.06.21251159v1 2/First, my Conflict of Interest: I am an employee of Helix.

Erin C. Sanders, MSN, WHNP-BC (She/Her/Hers)

ErinSandersNP

1/ THREAD: Chagas Disease, the Vagus Nerve and #SARS_CoV_2 So, I was thinking more about #COVID19 and the continued neurologic symptoms that are reported specifically by #LongHaulers with #LongCovid. Particularly,

Zoë McLaren, PhD

ZoeMcLaren

Scaling up rapid screening tests for COVID-19 is well within reach. They can help keep the virus at bay until a vaccine is available. My piece in The @ConversationUS explains.

Alasdair Munro

apsmunro

I have seen some repeated assertions about the evidence on #COVID19, children and schools recently which sound convincing, but unfortunately are falseIt is a sensitive and important topic, which is

Dave Curtis

davecurtis314

1/ Gather round children, I've a story to tell you. It's about how rare variants in the DNMT3A gene cause high blood pressure. In humans. The result is significant at

Jillian Hurst

hjillianh

SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study | medRxivhttps://www.medrxiv.org/content/10.1101/2020.08.18.20166835v1 A prospective cohort study evaluating #SARSCoV2 exposure

Joshua Weitz

joshuasweitz

Announcing: brief report for Fall 2020 intervention surveillance @GeorgiaTech represents the work of many, released to help inform, guide, and improve efforts to use viral testing as part of integrative

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.